Skip to main content
Top
Published in: Rheumatology International 12/2014

01-12-2014 | Original Article

Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome

Authors: Godasi S. R. S. N. K. Naidu, Aman Sharma, Ritambra Nada, Harbir Singh Kohli, Vivekanand Jha, Krishan Lal Gupta, Vinay Sakhuja, Manish Rathi

Published in: Rheumatology International | Issue 12/2014

Login to get access

Abstract

Rapidly progressive renal failure is a common but severe feature of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. A histopathological classification for ANCA-associated pauci-immune glomerulonephritis was developed for prognostication of these patients. The present study aims to classify patients of pauci-immune glomerulonephritis according to this classification and its impact on outcome. Eighty-six subjects with pauci-immune glomerulonephritis between July 2006 and October 2012 were included in the study. Their renal biopsies were reviewed and classified into focal, crescentic, sclerotic and mixed class as per the new classification. The outcomes were analyzed after 6 months of treatment. Of the 86 subjects, 34 (39.53 %) were granulomatosis with polyangiitis, 36 (41.86 %) microscopic polyangiitis, 1 eosinophilic granulomatosis with polyangiitis, while the rest (17.44 %) were unclassifiable. Thirteen (15.5 %), 43 (51.2 %), 12 (14.3 %) and 16 (19 %) patients were classified as focal, crescentic, sclerotic and mixed class, respectively. The mean serum creatinine at baseline was 280.23, 659.46, 573.72 and 542.78 µmol/L in focal, crescentic, sclerotic and mixed class, respectively. The probability of improvement in renal functions at 6 months decreased from focal to crescentic to mixed to sclerotic class, while the probability of death was highest in the sclerotic class followed by the mixed class. This difference in outcome was maintained irrespective of the clinical diagnosis or the Birmingham Vasculitis Activity Score. Our study has shown that the histopathological classification can be used to predict the severity of renal dysfunction as well as the treatment outcomes in pauci-immune glomerulonephritis.
Literature
1.
go back to reference de Lind Van Wijngaarden RA, Hauer HA, Wolterbeek R et al (2006) Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17:2264–2274PubMedCrossRef de Lind Van Wijngaarden RA, Hauer HA, Wolterbeek R et al (2006) Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17:2264–2274PubMedCrossRef
2.
go back to reference Berden AE, Ferrario F, Hagen EC et al (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21:1628–1636PubMedCrossRef Berden AE, Ferrario F, Hagen EC et al (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21:1628–1636PubMedCrossRef
3.
go back to reference Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ, the Glomerular Disease Collaborative Network (1996) Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7:23–32PubMed Hogan SL, Nachman PH, Wilkman AS, Jennette JC, Falk RJ, the Glomerular Disease Collaborative Network (1996) Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7:23–32PubMed
4.
go back to reference Day CJ, Howie AJ, Nightingale P, Shabir S, Adu D, Savage CO, Hewins P (2010) Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine. Am J Kidney Dis 55:250–258PubMedCentralPubMedCrossRef Day CJ, Howie AJ, Nightingale P, Shabir S, Adu D, Savage CO, Hewins P (2010) Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine. Am J Kidney Dis 55:250–258PubMedCentralPubMedCrossRef
5.
go back to reference Rais-Jalali G, Khajehdehi P (1999) ANCA-associated glomerulonephritis: relationship of main ANCA subtypes to renal outcome, age and sex of the patients. Ann Saudi Med 19:413–416PubMed Rais-Jalali G, Khajehdehi P (1999) ANCA-associated glomerulonephritis: relationship of main ANCA subtypes to renal outcome, age and sex of the patients. Ann Saudi Med 19:413–416PubMed
6.
go back to reference Kaplan-Pavlovcic S, Cerk K, Kveder R, Lindic J, Vizjak A (2003) Clinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis in elderly patients. Nephrol Dial Transplant 8(Suppl 5):S5–S7CrossRef Kaplan-Pavlovcic S, Cerk K, Kveder R, Lindic J, Vizjak A (2003) Clinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis in elderly patients. Nephrol Dial Transplant 8(Suppl 5):S5–S7CrossRef
7.
go back to reference Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143:621–631PubMedCrossRef Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143:621–631PubMedCrossRef
8.
go back to reference Alexopoulos E, Gionanlis L, Papayianni E, Kokolina E, Leontsini M, Memmos D (2006) Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN). BMC Nephrol 7:16PubMedCentralPubMedCrossRef Alexopoulos E, Gionanlis L, Papayianni E, Kokolina E, Leontsini M, Memmos D (2006) Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN). BMC Nephrol 7:16PubMedCentralPubMedCrossRef
9.
go back to reference Ahn JK, Hwang JW, Lee J, Jeon CH, Cha HS, Koh EM (2012) Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea. Rheumatol Int 32:2979–2986PubMedCrossRef Ahn JK, Hwang JW, Lee J, Jeon CH, Cha HS, Koh EM (2012) Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea. Rheumatol Int 32:2979–2986PubMedCrossRef
10.
go back to reference Flossmann O, Berden A, de Groot K et al (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70:488–494PubMedCrossRef Flossmann O, Berden A, de Groot K et al (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70:488–494PubMedCrossRef
11.
go back to reference Sinico RA, Toma LD, Radice A (2013) Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev 12:477–482PubMedCrossRef Sinico RA, Toma LD, Radice A (2013) Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev 12:477–482PubMedCrossRef
12.
go back to reference Gigante A, Salviani C, Giannakakis K et al (2012) Clinical and histological outcome predictors in renal limited pauci-immune crescentic glomerulonephritis: a single centre experience. Int J Immunopathol Pharmacol 25:287–292PubMed Gigante A, Salviani C, Giannakakis K et al (2012) Clinical and histological outcome predictors in renal limited pauci-immune crescentic glomerulonephritis: a single centre experience. Int J Immunopathol Pharmacol 25:287–292PubMed
13.
go back to reference Rupcic V, Jakic M, Rupcic V, Viziak V, Fijacko M (2011) Clinical course and outcome predictors in pauci-immune ANCA positive renal limited vasculitis. Acta Clin Croat 50:475–483PubMed Rupcic V, Jakic M, Rupcic V, Viziak V, Fijacko M (2011) Clinical course and outcome predictors in pauci-immune ANCA positive renal limited vasculitis. Acta Clin Croat 50:475–483PubMed
14.
go back to reference Itabashi M, Takei T, Yabuki Y (2010) Clinical outcome and prognosis of anti-neutrophil cytoplasmic antibody associated vasculitis in Japan. Nephron Clin Pract 115:c21–27PubMedCrossRef Itabashi M, Takei T, Yabuki Y (2010) Clinical outcome and prognosis of anti-neutrophil cytoplasmic antibody associated vasculitis in Japan. Nephron Clin Pract 115:c21–27PubMedCrossRef
16.
17.
go back to reference Lane SE, Watts RA, Shepstone L, Scott DGI (2005) Primary systemic vasculitis: clinical features and mortality. Q J Med 98:97–111CrossRef Lane SE, Watts RA, Shepstone L, Scott DGI (2005) Primary systemic vasculitis: clinical features and mortality. Q J Med 98:97–111CrossRef
18.
go back to reference Itabashi M, Yumura W, Tsukada M, Shirota S, Takei T, Ogawa T, Yoshida T, Uchida K, Tsuchiya K, Nitta K (2008) Clinico-histopathological analysis of renal changes in MPO ANCA associated vasculitis. Nihon Jinzo Gakkai Shi 50:927–933PubMed Itabashi M, Yumura W, Tsukada M, Shirota S, Takei T, Ogawa T, Yoshida T, Uchida K, Tsuchiya K, Nitta K (2008) Clinico-histopathological analysis of renal changes in MPO ANCA associated vasculitis. Nihon Jinzo Gakkai Shi 50:927–933PubMed
19.
go back to reference Chang D, Wu L, Liu G, Chen M, Kallenberg CGM, Zhao MH (2012) Re-evaluation of the histopathological classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single centre. Nephrol Dial Transplant 27:2343–2349PubMedCrossRef Chang D, Wu L, Liu G, Chen M, Kallenberg CGM, Zhao MH (2012) Re-evaluation of the histopathological classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single centre. Nephrol Dial Transplant 27:2343–2349PubMedCrossRef
20.
go back to reference Martinez-Morillo M, Grados D, Naranjo-Hans D, Mateo L, Holgado S, Olive A (2012) Granulomatosis with polyangiitis (Wegner). Description of 15 cases. Reumatol Clin 8:15–19PubMedCrossRef Martinez-Morillo M, Grados D, Naranjo-Hans D, Mateo L, Holgado S, Olive A (2012) Granulomatosis with polyangiitis (Wegner). Description of 15 cases. Reumatol Clin 8:15–19PubMedCrossRef
21.
go back to reference Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488–498PubMedCrossRef Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488–498PubMedCrossRef
22.
go back to reference Seck SM, Dussol B, Brunet P, Burtey S (2012) Clinical features and outcomes of ANCA associated renal vasculitis. Saudi J Kidney Dis Transplant 23:301–305 Seck SM, Dussol B, Brunet P, Burtey S (2012) Clinical features and outcomes of ANCA associated renal vasculitis. Saudi J Kidney Dis Transplant 23:301–305
23.
go back to reference Mahr A, Katsahian S, Varet H, for the French Vasculitis Study Group (FVSG) and the European Vasculitis Society (EUVAS) et al (2013) Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody associated vasculitis: a cluster analysis. Ann Rheum Dis 72:1003–1010PubMedCrossRef Mahr A, Katsahian S, Varet H, for the French Vasculitis Study Group (FVSG) and the European Vasculitis Society (EUVAS) et al (2013) Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody associated vasculitis: a cluster analysis. Ann Rheum Dis 72:1003–1010PubMedCrossRef
24.
go back to reference Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, Jarrousse B, French Vasculitis Study Group (2001) Long term follow up of polyarteritis nodosa, microscopic polyangiitis and Churg–Strauss syndrome. Arthritis Rheum 44:666–675PubMedCrossRef Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, Jarrousse B, French Vasculitis Study Group (2001) Long term follow up of polyarteritis nodosa, microscopic polyangiitis and Churg–Strauss syndrome. Arthritis Rheum 44:666–675PubMedCrossRef
25.
go back to reference Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D (2003) Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis 41:539–549PubMedCrossRef Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D (2003) Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis 41:539–549PubMedCrossRef
26.
go back to reference Suppiah R, Mukhtyar C, Flossmann O (2011) A cross sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology (Oxford) 50:899–905CrossRef Suppiah R, Mukhtyar C, Flossmann O (2011) A cross sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology (Oxford) 50:899–905CrossRef
27.
go back to reference Frausova D, Brejnikova M, Hruskova Z, Rihova Z, Tesar V (2008) Outcome of thirty patients with ANCA associated renal vasculitis admitted to the intensive care unit. Ren Fail 30:890–895PubMedCrossRef Frausova D, Brejnikova M, Hruskova Z, Rihova Z, Tesar V (2008) Outcome of thirty patients with ANCA associated renal vasculitis admitted to the intensive care unit. Ren Fail 30:890–895PubMedCrossRef
28.
go back to reference Iwakiri T, Fujimoto S, Kitagawa K (2013) Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. BMC Nephrol 14:125PubMedCentralPubMedCrossRef Iwakiri T, Fujimoto S, Kitagawa K (2013) Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. BMC Nephrol 14:125PubMedCentralPubMedCrossRef
29.
go back to reference Dadoniene J, Pileckyte M, Baranauskaite A, Kirdaite G (2010) Clinical characteristics and long-term outcomes of 35 patients with Wegener’s granulomatosis followed up at two rheumatology centers in Lithuania. Medicina (Kaunas) 46:256–260 Dadoniene J, Pileckyte M, Baranauskaite A, Kirdaite G (2010) Clinical characteristics and long-term outcomes of 35 patients with Wegener’s granulomatosis followed up at two rheumatology centers in Lithuania. Medicina (Kaunas) 46:256–260
30.
go back to reference Kamali S, Erer B, Artim-Esen B, Gul A, Ocal L, Konice M, Aral O, Inanc M (2010) Predictors of damage and survival in patients with Wegener’s granulomatosis: analysis of 50 patients. J Rheumatol 37:374–378PubMedCrossRef Kamali S, Erer B, Artim-Esen B, Gul A, Ocal L, Konice M, Aral O, Inanc M (2010) Predictors of damage and survival in patients with Wegener’s granulomatosis: analysis of 50 patients. J Rheumatol 37:374–378PubMedCrossRef
31.
go back to reference Stevic R, Jovanovic D, Obradovic LN, Milenkovic B, Skodric-Trifunovic V, Stankovic I (2012) Wegener’s granulomatosis: clinic-radiological finding at initial presentation. Coll Antropol 36:505–511PubMed Stevic R, Jovanovic D, Obradovic LN, Milenkovic B, Skodric-Trifunovic V, Stankovic I (2012) Wegener’s granulomatosis: clinic-radiological finding at initial presentation. Coll Antropol 36:505–511PubMed
32.
go back to reference De Souza FH, Radu Halpern AS, Valente Barbas CS, Shinio SK (2010) Wegener’s granulomatosis: experience from a Brazilian tertiary centre. Clin Rheumatol 29:855–860PubMedCrossRef De Souza FH, Radu Halpern AS, Valente Barbas CS, Shinio SK (2010) Wegener’s granulomatosis: experience from a Brazilian tertiary centre. Clin Rheumatol 29:855–860PubMedCrossRef
33.
go back to reference Tural C, Cuxart A, Bertran X, Puigdengoles X, Segura A, Rey-Joly C (1992) Granulomatosis de Wegener: descripcion de 6 pacientes. Med Clin 99:63–66 Tural C, Cuxart A, Bertran X, Puigdengoles X, Segura A, Rey-Joly C (1992) Granulomatosis de Wegener: descripcion de 6 pacientes. Med Clin 99:63–66
34.
go back to reference Ríos Blanco JJ, Gómez Cerezo J, Vázquez Muñoz E, Suárez García I, López Rodríguez M, Yébenes Gregorio L, Torres Sánchez I, Barbado Hernández FJ (2005) Clinical-biological and radiological study of Wegener’s granulomatosis in a university hospital. Rev Clin Esp 205:367–373PubMedCrossRef Ríos Blanco JJ, Gómez Cerezo J, Vázquez Muñoz E, Suárez García I, López Rodríguez M, Yébenes Gregorio L, Torres Sánchez I, Barbado Hernández FJ (2005) Clinical-biological and radiological study of Wegener’s granulomatosis in a university hospital. Rev Clin Esp 205:367–373PubMedCrossRef
35.
go back to reference Kapitsinou PP, Ioannidis JPA, Boletis JN, Sotsiou F, Nakopoulou L, Daphnis E, Moutsopoulos HM (2003) Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. Am J Kidney Dis 41:29–37PubMedCrossRef Kapitsinou PP, Ioannidis JPA, Boletis JN, Sotsiou F, Nakopoulou L, Daphnis E, Moutsopoulos HM (2003) Clinicopathologic predictors of death and ESRD in patients with pauci-immune necrotizing glomerulonephritis. Am J Kidney Dis 41:29–37PubMedCrossRef
36.
go back to reference Hauer HA, van Houwelingen HC, Bajema IM, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC, European Vasculitis Study Group (EUVAS) (2002) Renal histology in ANCA associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 61:80–89PubMedCrossRef Hauer HA, van Houwelingen HC, Bajema IM, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC, European Vasculitis Study Group (EUVAS) (2002) Renal histology in ANCA associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 61:80–89PubMedCrossRef
37.
go back to reference Vergunst CE, van Gurp E, Hagen EC et al (2003) An index for renal outcome in ANCA associated glomerulonephritis. J Kidney Dis 41:532–538CrossRef Vergunst CE, van Gurp E, Hagen EC et al (2003) An index for renal outcome in ANCA associated glomerulonephritis. J Kidney Dis 41:532–538CrossRef
Metadata
Title
Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome
Authors
Godasi S. R. S. N. K. Naidu
Aman Sharma
Ritambra Nada
Harbir Singh Kohli
Vivekanand Jha
Krishan Lal Gupta
Vinay Sakhuja
Manish Rathi
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 12/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-014-3041-z

Other articles of this Issue 12/2014

Rheumatology International 12/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.